Americas Transplant Pathogen Monitoring Market
Americas Transplant Pathogen Monitoring Market Analysis by Test Kits (CMV PCR Kits, EBV PCR Kits,BKV PCR Kits), by Sample (Blood Serum, Plasma, Swabs Sample), By Distribution Channel, By Region - Global Insights 2021-2031
Analysis of Americas Transplant Pathogen Monitoring market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Americas Transplant Pathogen Monitoring
Newly released data from Fact.MR’s industry analysis on transplant pathogen monitoring in the Americas shows that the market enjoyed year-on-year (YoY) growth of 6.7% in 2021. Revenue from CMV PCR kits, EBV PCR kits, BKV PCR kits, aspergillus test kits, and multiplex PCR kits totaled US$ 298.8 Mn, according to the research conducted by Fact.MR, a market research and competitive intelligence provider.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Demand Analysis of Transplant Pathogen Monitoring from 2016-2020 Vs Market Outlook for 2021-2031
The transplant pathogen monitoring market is projected to expand at a CAGR of 6.7% from 2021 to 2031 in comparison to the above 6% CAGR registered during 2016-2020. This is driven by increasing geriatric population, rising incidence of chronic diseases, and an increasing burden of infectious diseases.
Increasing public-private funding for target research activities and technological advancements such as the application of STR-PCR and HLA typing in the field of transplant pathogen monitoring further accentuate market growth.
Furthermore, there is an increasing inclination towards preventive care testing and public awareness of organ transplants and organ donation. Increased risk in transplant patients due COVID-19 infection further introduced widespread need for transplant pathogen monitoring for the post-transplant period.
Technological advancements and their applications and innovative solutions to enhance healthcare facilities have positively affected the transplant pathogen monitoring scenario.
Blood sample crossmatch is the most widely adopted test for transplant pathogen monitoring. However, swab sample testing appears to present the most lucrative opportunities for market players, and is set to expand at a CAGR of 8.9%.
Demand growth of transplant pathogen monitoring is further augmented by increasing adoption of cross-matching and chimerism testing through the post-transplantation process.
What is the Impact of Increasing Number of Infections on Transplant Pathogen Monitoring?
The major risk of complications throughout the process of transplantation is the occurrence of infections. Infectious risks at an early stage are primarily related to postoperative and nosocomial infections. Opportunistic infections such as Cytomegalovirus occur after a significant time post-transplant, and are the most common cause of viral infections in transplant patients.
Adoption of transplant pathogen monitoring for an increased association of such infections is critical throughout the intermediate phase. The risk of community-acquired infections in transplant patients is highly common.
Prevalence of cytomegalovirus reflects that 50% of adults are infected with CMV by the age of 40, and over one in three children are infected by the age of 5 in the U.S., as per the Centers for Disease Control and WHO in 2019.
Early treatment of infections through transplantation diagnostic procedures is an efficient method for an advanced prognosis in patients with severe infections due to organ transplants.
Country-wise Insights
How Big is the U.S. Market for Transplant Pathogen Monitoring?
The U.S. transplant pathogen monitoring market dominates the region, and is expected to witness steady growth during the forecast period, according to Fact. MR.
The market analysis by Fact.MR shows the U.S. accounting for a market share of 67% in 2021. This leading stance is governed by the presence of an advanced healthcare system and the presence of major players in transplant pathogen monitoring.
High adoption of innovative transplant pathogen monitoring technologies among medical specialists and rising number of procedures involving organ transplantation in the country further augment market growth in the country.
Apart from these factors, there is high adoption of soft tissue transplants in the country, which are also augmenting market growth.
Why is Demand for Transplant Pathogen Monitoring Increasing in Canada?
The Canadian market is increasingly witnessing growing availability in transplant pathogen monitoring products, and is expected to witness a CAGR of 7.2% over the forecast period.
Growth is supported by increasing government initiatives and collaboration in transplant processes. Health Canada, by the government of Canada, leads an initiative called Organ Donation and Transplantation Collaborative, with the goal of improved patient outcomes and successful transplantation processes.
Rising availability of transplant pathogen monitoring products and services and prevalence of various government initiatives are set to promote market expansion in the country.
What is the Outlook for Transplant Pathogen Monitoring in Brazil?
The Brazil transplant pathogen monitoring market holds a current market share of 34.5%, and according to the analysis by Fact.MR, is expected to present high growth at a CAGR of 5.8% over the next ten years.
This growth is associated with the presence of favorable opportunities for organ procurement through donors. Brazil ranks first in the number of kidney transplantation procedures. Due to increasing number of organ transplantation patients, the wait time for these procedures is increasing.
Transplant pathogen monitoring is potentially linked to the practice of decreased waiting times through technological advancements. One such example is the application of machine learning approaches with evaluated predictors of comorbidities and infection-related data.
How is Mexico Faring in the Transplant Pathogen Monitoring Space?
In 2031, Mexico is set to account for over 30% of the market share as compared to a share of 28.7% at present. Growth in transplant pathogen monitoring is augmented by increasing number of organ transplant procedures within the country.
According to the National Transplant Center database, from the period of 2007-2019, over 34,931 transplants were performed in Mexico. The study indicated a rise in the number of transplant procedures from 18.9 per million population to 23.3 per million population annually.
High presence of transplant procedures and suggestive increase in their number have proven to be an augmentative factors for transplant pathogen monitoring throughout Mexico.
What is the Transplant Pathogen Monitoring Adoption Scenario in Argentina?
The Argentina transplant pathogen monitoring market is expected to expand the fastest at a CAGR of 8.6%. Increasing number of guidelines and recommendations over transplantation processes as well as diseases associated with it have led to high growth opportunity in Argentina.
A.A.E.E.H has developed a clinical practice guideline for surveillance, diagnosis, staging, and treatment of hepatocellular carcinoma, where the guidelines for surveillance of HCC are included. Such procedures have led to the initiation of rising transplant pathogen monitoring processes in Argentina.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Why is Demand for Test Kits for Transplant Pathogen Monitoring Continuously Rising?
Test kits are used for rapid as well as accurate detection of infectious agents before a transplantation procedure. Based on product, BKV PCR kits is leading in terms of market share, estimated at 32.2% as of 2021.
The BK virus is highly prevalent in the general population, often as an asymptomatic polyomavirus. BKV is a major cause of infection in immunocompromised patients after a kidney transplant or hematopoietic stem cell transplant. This poses the problem of renal dysfunction.
Thus, the monitoring and diagnosis of BKV is extremely vital for the prevention of renal diseases and transplant failure. BKV PCR kits are real-time PCR assay kits intended for the detection as well as quantification of BKV DNA.
Why is Blood Serum Preferred as a Sample for Transplant Pathogen Monitoring?
Blood serum is the most widely adopted method of sampling for solid organ transplant pathogen monitoring. The segment is projected to expand at a CAGR of 5.5% over the forecast period.
Increasing adoption of serum crossmatch and rising technological advancements in transplant pathogen monitoring for transplant procedures concerning blood serum samples have led to an increased preference for blood serum as a sample for transplant pathogen monitoring.
The value of blood serum sample is expected to reach US$ 290 Mn by the end of the forecast period.
Why are Diagnostic Laboratories Flourishing Distribution Channels of Transplant Pathogen Monitoring?
Based on distribution channel, diagnostic laboratories depict a market share of 27.2% and are projected to increase at a CAGR of 7.6% over the next ten years.
Revenue from diagnostic laboratories is projected to account for over US$ 169.4 Mn by 2031. This growth is supported by advancements in serology and cellular assays. The need for improving the process for a successful transplant procedure has further led to the evolution of diagnostic laboratories.
How Has COVID-19 Affected the Transplant Pathogen Monitoring Industry?
The impact of the COVID-19 pandemic as an infectious disease resulted in a momentary halt on transplant procedures; however, diagnostic procedures were supported after a stagnant period during 2020.
The pandemic impacted donor and recipient suitability and mitigation of the presence of infection and its transmission. Various clinical specimens, including plasma and swab sample testing for the detection of infections concerning COVID-19 increased demand for transplant pathogen monitoring, along with donor and receiver screening for COVID-19-related infections during the pre-transplantation process as well as the post-transplantation process.
Moreover, rising awareness among the general population about the impact of COVID-19 infection and its prospective complications in transplant processes, as well as rise in technological advancements are set to propel demand for transplant pathogen monitoring over the coming years.
Competitive Landscape
Companies operating in the American transplant pathogen monitoring market are focused on innovative solutions to decrease the increasing burden of patient numbers for transplant procedures. This factor has encouraged key players to bring innovative solutions in transplant pathogen monitoring for infection monitoring as well as alternative methods for organ transplant surgeries.
Top American transplant pathogen monitoring companies also focus on geographical expansions to generate a larger footprint for sales of products and services.
- For instance, in 2020, Bio Rad Laboratories, Inc. launched the Exact Diagnostics Transplant product range in the European market for quality control of transplant procedures. The company set a firm footprint in the region with the launch of a product portfolio for transplant-associated infections.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Americas Transplant Pathogen Monitoring Market Report Scope
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
| Report Coverage |
|
| Customization & Pricing |
Available upon Request |
Categories of Transplant Pathogen Monitoring Industry Research
-
Transplant Pathogen Monitoring Test Kits
- CMV PCR Kits
- EBV PCR Kits
- BKV PCR Kits
- Aspergillus Test Kits
- Multiplex PCR Kits
-
Transplant Pathogen Monitoring by Sample
- Blood Serum Sample Transplant Pathogen Monitoring
- Plasma Sample Transplant Pathogen Monitoring
- Swabs Sample Transplant Pathogen Monitoring
- Urine Sample Transplant Pathogen Monitoring
-
Distribution Channel
- Hospitals
- Diagnostic Laboratories
- Cancer Research Institutes
- Specialty Centers
Table of Content
1. Executive Summary 1.1. Americas Market Outlook 1.2. Supply Side Trends 1.3. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Transplant Pathogen Monitoring Market 3.2. Innovation / Development Trends 4. Market Context 4.1. Recent developments and Product Launches 4.2. Key Marketing Strategies, by Manufacturers 4.3. Regulatory guidelines 5. Market Background 5.1. Macro-Economic Factors 5.1.1. GDP Growth Outlook 5.1.2. Per-Capita Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Cost Per Tests 5.2.2. Number of Transplantation procedures Performed Annually 5.2.3. Strategic Acquisitions and Mergers 5.2.4. New product launches 5.2.5. Need for Pre-Transplant Screening 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. COVID19 and Impact Analysis 6.4. Recovery Scenario – Short term, Midterm and Long Term Impact 7. Americas Transplant Pathogen Monitoring Demand (in Volume ‘000 Units) Analysis 2016-2020 and Forecast, 2021–2031 7.1. Historical Market Volume (‘000 Units) Analysis, 2016-2020 7.2. Current and Future Market Volume (‘000 Units) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 8. Americas Transplant Pathogen Monitoring Market - Pricing Analysis 8.1. Regional Pricing Analysis, By Product Type 8.2. Regional Average Pricing Analysis Benchmark 9. Americas Transplant Pathogen Monitoring Market Value Analysis 2016 – 2020 and Forecast, 2021 – 2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Americas Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Test 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test, 2016 – 2020 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Test, 2021 – 2031 10.3.1. CMV PCR Kits 10.3.2. EBV PCR Kits 10.3.3. BKV PCR Kits 10.3.4. Aspergillus Test Kits 10.3.5. Multiplex PCR Kits 10.4. Market Attractiveness Analysis By Test 11. Americas Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Sample 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Sample, 2016 – 2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample, 2021 – 2031 11.3.1. Blood Serum 11.3.2. Plasma 11.3.3. Swabs 11.3.4. Urine 11.4. Market Attractiveness Analysis By Sample 12. Americas Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2016 – 2020 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End user, 2021 – 2031 12.3.1. Hospitals 12.3.2. Diagnostic Laboratories 12.3.3. Cancer Research Institutes 12.3.4. Specialty Centers 12.4. Market Attractiveness Analysis By End User 13. Americas Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 – 2020 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 – 2031 13.3.1. U.S. 13.3.2. Canada 13.3.3. Latin America 13.4. Market Attractiveness Analysis By Region 14. U.S Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 – 2020 14.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2021 – 2031 14.3.1. By Test 14.3.2. By Sample 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Drivers and Restraints - Impact Analysis 15. Canada Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 – 2020 15.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2021 – 2031 15.3.1. By Test 15.3.2. By Sample 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Drivers and Restraints - Impact Analysis 16. Latin America Transplant Pathogen Monitoring Market Analysis 2016 – 2020 and Forecast 2021 – 2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 – 2020 16.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2021 – 2031 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Argentina 16.3.1.3. Mexico 16.3.1.4. Rest of Latin America 16.3.2. By Test 16.3.3. By Sample 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.5. Drivers and Restraints - Impact Analysis 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Deep Dive 18.2.1. bioMérieux SA 18.2.1.1. Overview 18.2.1.2. Product Portfolio 18.2.1.3. Sales Footprint 18.2.1.4. Strategy Overview 18.2.1.4.1. Marketing Strategy 18.2.1.4.2. Product Strategy 18.2.1.4.3. Channel Strategy 18.2.2. QIAGEN 18.2.2.1. Overview 18.2.2.2. Product Portfolio 18.2.2.3. Sales Footprint 18.2.2.4. Strategy Overview 18.2.2.4.1. Marketing Strategy 18.2.2.4.2. Product Strategy 18.2.2.4.3. Channel Strategy 18.2.3. ELITechGroup 18.2.3.1. Overview 18.2.3.2. Product Portfolio 18.2.3.3. Sales Footprint 18.2.3.4. Strategy Overview 18.2.3.4.1. Marketing Strategy 18.2.3.4.2. Product Strategy 18.2.3.4.3. Channel Strategy 18.2.4. Trinity Biotech Plc. 18.2.4.1. Overview 18.2.4.2. Product Portfolio 18.2.4.3. Sales Footprint 18.2.4.4. Strategy Overview 18.2.4.4.1. Marketing Strategy 18.2.4.4.2. Product Strategy 18.2.4.4.3. Channel Strategy 18.2.5. Bio-Rad Laboratories, Inc. 18.2.5.1. Overview 18.2.5.2. Product Portfolio 18.2.5.3. Sales Footprint 18.2.5.4. Strategy Overview 18.2.5.4.1. Marketing Strategy 18.2.5.4.2. Product Strategy 18.2.5.4.3. Channel Strategy 18.2.6. F. Hoffmann-La Roche Ltd 18.2.6.1. Overview 18.2.6.2. Product Portfolio 18.2.6.3. Sales Footprint 18.2.6.4. Strategy Overview 18.2.6.4.1. Marketing Strategy 18.2.6.4.2. Product Strategy 18.2.6.4.3. Channel Strategy 18.2.7. Abbott Laboratories 18.2.7.1. Overview 18.2.7.2. Product Portfolio 18.2.7.3. Sales Footprint 18.2.7.4. Strategy Overview 18.2.7.4.1. Marketing Strategy 18.2.7.4.2. Product Strategy 18.2.7.4.3. Channel Strategy 19. Assumptions and Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Transplant Pathogen Monitoring Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Test
Table 02: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Sample
Table 03: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 04: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 05: U.S Transplant Pathogen Monitoring Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Test
Table 06: U.S Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Sample
Table 07: U.S Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 08: Canada Transplant Pathogen Monitoring Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Test
Table 09: Canada Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Sample
Table 10: Canada Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 11: Latin America Transplant Pathogen Monitoring Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Test
Table 12: Latin America Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Sample
Table 13: Latin America Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 14: Latin America Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Transplant Pathogen Monitoring Market Value (US$ Mn) and Forecast, 2016-2031
Figure 02: Transplant Pathogen Monitoring Market Incremental $ Opportunity, 2021-2031
Figure 03: Transplant Pathogen Monitoring Market Analysis by Test –2021 & 2031
Figure 04: Transplant Pathogen Monitoring Market Y-o-Y Growth Projections by Test, 2021 – 2031
Figure 05: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Test
Figure 06: Transplant Pathogen Monitoring Market Analysis by Sample –2021 & 2031
Figure 07: Transplant Pathogen Monitoring Market Y-o-Y Growth Projections by Sample, 2021 – 2031
Figure 08: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Sample
Figure 09: Transplant Pathogen Monitoring Market Analysis by End User –2021 & 2031
Figure 10: Transplant Pathogen Monitoring Market Y-o-Y Growth Projections by End User , 2021 – 2031
Figure 11: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Figure 12: Transplant Pathogen Monitoring Market Analysis by Region –2021 & 2031
Figure 13: Transplant Pathogen Monitoring Market Y-o-Y Growth Projections by Region , 2021 – 2031
Figure 14: Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Figure 15: U.S Transplant Pathogen Monitoring Market Value (US$ Mn), Historical, 2016-2020
Figure 16: U.S Transplant Pathogen Monitoring Market Value (US$ Mn), Forecast, 2021-2031
Figure 17: U.S Transplant Pathogen Monitoring Market Attractiveness Analysis by Test, 2021-2031
Figure 18: U.S Transplant Pathogen Monitoring Market Attractiveness Analysis by Sample, 2021-2031
Figure 19: U.S Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Figure 20: Canada Transplant Pathogen Monitoring Market Value (US$ Mn), Historical, 2016-2020
Figure 21: Canada Transplant Pathogen Monitoring Market Value (US$ Mn), Forecast, 2021-2031
Figure 22: Canada Transplant Pathogen Monitoring Market Attractiveness Analysis by Test, 2021-2031
Figure 23: Canada Transplant Pathogen Monitoring Market Attractiveness Analysis by Sample, 2021-2031
Figure 24: Canada Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Figure 25: Latin America Transplant Pathogen Monitoring Market Value (US$ Mn), Historical, 2016-2020
Figure 26: Latin America Transplant Pathogen Monitoring Market Value (US$ Mn) Forecast, 2021-2031
Figure 27: Latin America Transplant Pathogen Monitoring Market Attractiveness Analysis by Test, 2021-2031
Figure 28: Latin America Transplant Pathogen Monitoring Market Attractiveness Analysis by Sample, 2021-2031
Figure 29: Latin America Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Figure 30: Latin America Transplant Pathogen Monitoring Market Size (US$ Mn) Analysis 2016-2020
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the Americas transplant pathogen monitoring market currently valued at?
The Americas transplant pathogen monitoring market is currently valued at close to US$ 300 Mn.
What will be the sales forecast of transplant pathogen monitoring for 2021 to 2031?
The market is expected to reach a value of US$ 570 Mn by the end of 2031, with sales revenue expected to register a CAGR of 6.7%.
What was the last 5 year’s market CAGR for transplant pathogen monitoring?
From 2016-2020, demand for transplant pathogen monitoring observed a growth rate of 6%.
What are the key trends shaping the market for transplant pathogen monitoring?
The market is benefitted by the shift towards next generation sequencing (NGS) to measure donor-derived cell-free DNA and strategic acquisitions by key manufacturers.
Which are the top countries driving demand for transplant pathogen monitoring?
The U.S., Brazil, and Argentina are expected to drive increased demand for transplant pathogen monitoring during the forecast period.
What is the U.S. market outlook for the next ten years?
The U.S. is one of the dominant markets for transplant pathogen monitoring, and is expected to account for 65.7% market share.
At what percentage is demand for transplant pathogen monitoring expected to register growth in Latin America?
Demand of transplant pathogen monitoring is anticipated to register growth rate of 7% in the Latin American region.
Which countries are key service providers of transplant pathogen monitoring?
The U.S, Canada, and Brazil are dominating the market. Brazil accounted for 33% market share in 2020.
What are the key market statistics for the U.S. and Brazil?
Demand for transplant pathogen monitoring in the U.S. and Brazil is expected to witness high volume growth at an anticipated value CAGR of 6.5% and 5.8%, respectively.
Americas Transplant Pathogen Monitoring Market